Australian women with period pain want medicinal cannabis but face major access barriers
Focus groups with 26 Australian women found dissatisfaction with current pain treatments drove interest in medicinal cannabis for period pain, but cost, prescriber bias, drug driving laws, and stigma blocked access.
Quick Facts
What This Study Found
Dissatisfaction with over-the-counter pain medication was the primary driver for wanting medicinal cannabis. Key barriers included difficulty finding willing prescribers, cost, current drug driving laws, geographic isolation, and persistent stigma around cannabis even when prescribed.
Key Numbers
26 women participated in virtual focus groups. All experienced regular moderate or greater menstrual pain. High cost of legal medicinal cannabis was identified as a key factor driving women to illicit cannabis instead.
How They Did This
Qualitative study using virtual focus groups with 26 Australian women experiencing regular moderate-to-severe menstrual pain. Explored perceptions of medicinal cannabis including cost, stigma, driving laws, workplace ethics, and geographic access.
Why This Research Matters
Period pain affects millions of women, and current treatments are often inadequate. This study captures the real-world barriers women face in accessing a treatment option they believe could help, even where it is legally available.
The Bigger Picture
The barriers identified mirror those found in broader Australian medicinal cannabis access studies, suggesting the problems are systemic rather than disease-specific and require regulatory solutions.
What This Study Doesn't Tell Us
Qualitative study with 26 participants cannot measure the prevalence of these views in the broader population. Recruited through social media, potentially attracting cannabis-favorable participants.
Questions This Raises
- ?Would government subsidization of medicinal cannabis increase legitimate access?
- ?Do the drug driving laws (which test for THC presence, not impairment) unfairly penalize medicinal users?
- ?Would clinical trials of cannabis for dysmenorrhea change prescriber attitudes?
Trust & Context
- Key Stat:
- Cost of legal cannabis drove women to illicit supply
- Evidence Grade:
- Preliminary: qualitative focus group study with 26 participants, cannot generalize to broader population.
- Study Age:
- Published in 2022.
- Original Title:
- "Should I Inhale?"-Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study.
- Published In:
- International journal of environmental research and public health, 19(3) (2022)
- Authors:
- Sinclair, Justin(14), Armour, Susanne, Akowuah, Jones Asafo, Proudfoot, Andrew, Armour, Mike
- Database ID:
- RTHC-04227
Evidence Hierarchy
Uses interviews or focus groups to understand experiences in depth.
What do these levels mean? →Frequently Asked Questions
Why do women want cannabis for period pain?
The primary driver was dissatisfaction with current over-the-counter pain medications, which many found inadequate for managing their symptoms.
What was the biggest barrier to access?
Multiple barriers emerged, but cost and difficulty finding a prescriber willing to recommend cannabis were among the most significant. Drug driving laws that test for THC presence (not impairment) were also a major concern.
Is there evidence cannabis helps with period pain?
The authors note that clinical trials of cannabis for primary dysmenorrhea are urgently needed. Current evidence is mostly anecdotal.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04227APA
Sinclair, Justin; Armour, Susanne; Akowuah, Jones Asafo; Proudfoot, Andrew; Armour, Mike. (2022). "Should I Inhale?"-Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study.. International journal of environmental research and public health, 19(3). https://doi.org/10.3390/ijerph19031536
MLA
Sinclair, Justin, et al. ""Should I Inhale?"-Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study.." International journal of environmental research and public health, 2022. https://doi.org/10.3390/ijerph19031536
RethinkTHC
RethinkTHC Research Database. ""Should I Inhale?"-Perceptions, Barriers, and Drivers for Me..." RTHC-04227. Retrieved from https://rethinkthc.com/research/sinclair-2022-should-i-inhaleperceptions-barriers
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.